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Introduction
In patients with kidney failure cardiovascular complications are 
a major clinical problem. The most important is left ventricular 
hypertrophy and the main cause of death in these patients is 
due to cardiac problems (1,2). Cardiac risk is increased with 
much more frequency in hemodialysis patients, compared 
with age matched controls (1-3). It had been known for a long 
time that plaque in arteries are more frequent in patients on 
hemodialysis (1). In fact patients under dialysis suffer from 
excessive mortality due to atherosclerotic cardiovascular disease 
in comparison to general population (4). This is frequently 
attributed to the rapid progressive atherosclerosis. Indeed, 
various risk factors of atherosclerotic cardiovascular disease 
in the general population such as lipid abnormalities, glucose 
intolerance, hypertension and left ventricular hypertrophy are 
more commonly observed in hemodialysis (4,5). Ultrasonic 
assessment of plaques in the carotid and femoral arteries are 
extensively used as a surrogate marker of atherosclerosis in 
coronary arteries (3). However, prospective evaluations about 
the association of arterial plaque with hypertrophy of left 
ventricle and also left ventricular ejection fraction are scares 
and seems to be lacking in hemodialysis patients.
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Implication for health policy/practice/research/medical education:
In a study on sixty-one patients, who were on regular hemodialysis, a significant positive association between left ventricular hypertrophy and 
plaque score was found. The present investigations, documents parallel cardiac and vascular adaptation in hemodialysis patients and shows 
the potential contribution of structural and functional large artery alteration to the pathogenesis of left ventricular hypertrophy which needs 
more attention in patients on hemodialysis.
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Introduction: In renal failure patients, cardiovascular complications are a major clinical problem.
Objectives: This study aimed to test, the possible association of left ventricular hypertrophy and ejection 
fraction with plaques of carotid and femoral artery hemodialysis.
Patients and Methods: Sixty-one patients, who were on regular hemodialysis were selected. For all 
patients echocardiography and B-mode Ultrsonographic assessment of carotid-femoral arteries for 
plaque occurrence were conducted.
Results: In this study there was a positive correlation between left ventricular hypertrophy with the 
duration of hemodialysis treatment (p<0.05). Significant positive association between left ventricular 
hypertrophy and plaque score and also a significant positive association between left ventricular 
hypertrophy with presence of chest pain was found (p<0.05). Association of diabetes mellitus with the 
presence of chest pain was positive. Positive correlation between hypertension with plaque score was 
demonstrated too (p<0.05). Also an inverse association of plaque score with left ventricular ejection 
fraction was detected too (p<0.05). Furthermore, the correlation of plaque score with the presence of 
diabetes mellitus was positive. 
Conclusion: The present investigations, documents parallel cardiac and vascular adaptation in 
hemodialysis patients and shows the potential contribution of structural and functional large artery 
alteration to the pathogenesis of left ventricular hypertrophy which needs more attention in patients on 
hemodialysis.
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Objectives
In this study we, sought to examine whether any association 
is exist between carotid-femoral artery plaques with left 
ventricular hypertrophy and left ventricular ejection fraction of 
hemodialysis patients?
Patients and Methods 
This cross-sectional investigation, conducted on patients 
on regular hemodialysis. Exclusion criteria were anti lipid 
drug tacking, recent myocardial infarction, vascular diseases, 
pericarditis or pericardial effusion in echocardiography and 
presence of any active or chronic infection. For categorization 
of hypertensive patients according to the sixth report of the 
joint national committee on prevention, detection, evaluation 
and treatment of high blood pressure, we stratified hypertensive 
patients from stage one to three (6,7) (stage of zero equal to 
no hypertension). Stages of the hypertension of hemodialysis 
patients were measured before treatment and at the first start 
of hemodialysis treatment. Carotid sonography was conducted 
by a single sonologist   unaware   of    data of patients. Using 
a Honda-Hs-2000 Sonograph with 7.5 MHZ linear probe, the 
procedure was performed at the end of diastolic phase. The 
sites of measurements were at the distal common carotid artery, 
area of bifurcation and at the first proximal internal carotid 
artery. For examination, subjects were in supine position with 
neck hyperextension and rotation of head for facilitation of 
procedure performing. Sonography for plaques was conducted 
at the right and left of carotid and femoral arteries and scored 
from 0 (no plaque) to score 4 (plaque presence at all four sites). 
Irrespective of the number and size of the plaques in each 
site, plaque occurrence in each site, scored one point. Plaques 
divided into 3 groups, soft, calcified and mixed. Plaques was 
considered as a local intimal thickness more than 1 mm. For 
cardiac echocardiography, one single cardiologist who was 
unaware of the patients data performed all echocardiography 
[Two-Dimensional Echocardiogram (2D Echo) and Doppler]. 
For left ventricular hypertrophy on the base of sepal thickness, 
we stratified the patients into no left ventricular hypertrophy 
(septal thickness between 6-11 mm), mild (septal thickness 
between 11-15 mm), moderate (septal thickness between 15-18 
mm) and severe left ventricular hypertrophy (septal thickness 
>18 mm). Left ventricular hypertrophy, measured at the end 
diastolic phase. Left ventricular ejection fraction between 55 to 
75% was considered normal.
Ethical approval
All patients signed the consent form for participation in this 
study. Research study was approved by the ethics committee of 
Shahrekord University of Medical Sciences, Iran.
Statistical analysis
For statistical analysis descriptive data were expressed as Mean 
(SD) and frequency distributions. Comparison between groups 
were performed using Chi-square, Mann Whitney U, Kruskal-
Wallis and Fisher’s exact tests. For correlations Spearman’s rho 
test, partial correlation test with adjustment for ages of patients, 
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Phi & Cramer’s V, Pearson and Eta tests were applied too. All 
statistical analysis were performed using the SPSS (version 
11.00). Statistical significance was inferred at a p value< 0.05. 
Results
 The total patients were 61. Table 1 shows the mean of data. Tables 
2, 3 and 4 show the frequency distributions of chest pain, stages 
of hypertension and stages of LVH. Table 5 shows  the frequency 
distribution of plaque score. Mean of age of patients were 46.5 
(16) years. The duration of dialysis were 32 (31) months. Mean 
of left ventricular ejection fraction was 51 (8.9) percent. Also 
39.3% of patients had chest pain. In this study there were no 
significant difference of age, percent of left ventricular ejection 
fraction and duration of dialysis  treatment between males and 
females  (p>0.05). There was no significant difference of left 
ventricular hypertrophy between two sexes (p>0.05). There was 
not significant difference  in the presence of chest pain between 
two sexes  (p>0.05). No significant difference of duration of 
hemodialysis treatment, ages of the patients and percent of left 
ventricular ejection fraction between diabetic and non-diabetic 
group were existed (p>0.05). In this study there was a positive 
association between left ventricular hypertrophy and duration 
of hemodialysis (r=0.337, p=0.004) was observed. No significant 
association between left ventricular hypertrophy and ages of 
the patients was existed (p>0.05). No significant correlation 
between diabetes mellitus and left ventricular hypertrophy 
(p>0.05) was found. Significant positive correlation between 
presence of chest pain and DM (p<0.001) was found. In 
patients, a significant correlation between presence of chest 
pain and left ventricular hypertrophy (p<0.001) was observed. 
Linear inverse correlation of plaque score with percent of left 
ventricular ejection fraction was detected (r= -0.404, p=0.001). 
A significant positive association between plaque score and 
presence of diabetes mellitus was observed (p=0.004). Also, 
a significant positive correlation between plaque score with 
left ventricular hypertrophy (r= 0.259, p=0.023) was found. 
Moreover, a significant positive association between plaque 
score and duration of dialysis (r= 0.239, p=0.033) and a positive 
correlation between plaque score with stages of hypertension 
(r= 0.240, p=0.032) was detected too.
Table 1. Mean (SD), minimum and maximum of patients’  data
Age
(years)
D.H.T*
(months)
EF**
(%)
Total 
patients
Mean(SD) 46.5±16 32±31 51±8.9
Min 15 2 25
Max 78 108 70
Diabetic 
group 
Mean(SD) 57±16 22.6±22.4 47.7±7
Min 27 3 30
Max 78 60 55
Non-diabetic 
group 
Mean(SD) 47.8±16 34±33 51±9
Min 15 2 25
Max 78 108 70
*Duration of hemodialysis treatment.
**LV ejection fraction.
Arterial plaques  and  ventricular hypertrophy in hemodialysis 
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Table 2. Frequency distribution of stages of hypertension (HTN)
Stages of HTN
Total patients DM group* Non-DM group
Number Percent Number Percent Number Percent
0 4 6.6 0 0 4 8
1 5 8.2 0 0 5 10
2 33 54.1 8 72.7 25 50
3 19 31.1 3 27.3 16 32
*DM=Diabetes Mellitus.
Table 3. Frequency distribution of chest pain in hemodialysis patients.
Chest pain
Total patients Diabetic patients Non diabetic patients
Number Percent Number Percent Number Percent
Yes 24 39.3 9 81.8 15 30
No 34 60.7 2 18.2 35 70
Table 4. Frequency distribution of Left ventricular hypertrophy (LVH) in hemodialysis patients.
Total patients Diabetic patients Non diabetic patients 
Number Percent Number Percent Number Percent
No LVH 9 14.8 1 9 8 16
Mild LVH 25 41 4 36.4 21 42
Moderate LVH 20 32.8 4 36.4 16 32
Severe LVH 7 11.5 2 18.2 5 10
Discussion
In this study, we found a positive association between left 
ventricular hypertrophy and duration of dialysis was seen. An 
inverse correlation of plaque score with percent of left ventricular 
ejection fraction was found. A significant correlation between 
plaque score with left ventricular hypertrophy and also a positive 
correlation between plaque score with duration of dialysis 
was detected. Studies regarding the arterial plaques and left 
ventricular hypertrophy in dialysis patients showed interesting 
findings. Strauman et al. (8) in an investigation on 62 patients 
on maintenance hemodialysis observed, 65% prevalence of 
left ventricular hypertrophy. They showed, age, body mass 
index, and duration of hypertension was associated with left 
ventricular hypertrophy and asymmetric septal hypertrophy. 
Greaves et al. (9) in the evaluation of 30 hemodialysis and 54 
patients on peritoneal dialysis compared with 38 end-stage 
renal disease patients not yet on dialysis, demonstrated that 
left ventricular wall thickness was greater in dialysis group. De 
Lima et al. (10) in the study of 103 hemodialysis patients, found 
that, systolic blood pressure was significantly associated with 
left ventricular mass and was significantly and independently 
correlated with left ventricular hypertrophy and posterior wall 
hypertrophy. Hojs (11) in a study on 28 hemodialysis patients 
showed, age was the only significant determinant of number of 
plaques. More over in the recent study by Hojs, no difference 
in plaque occurrence between 28 hemodialysis patients with 
28 end-stage renal disease patients prior to hemodialysis was 
detected (11). Pascasio et al. detected a large number of vascular 
plaques in uremia patients which was statistically significant in 
Table 5. Frequency distribution of plaque score of carotid and femoral 
arteries.
Plaque score Number Percent
Total 
patients
0 33 54.1
1 5 8.1
2 12 19.7
3 2 3.3
4 9 14.8
Group one
0 1 9.1
1 1 9.1
2 6 54.5
3 0 0.0
4 3 27.3
Group two
0 32 64.0
1 4 8.0
2 6 12.0
3 2 4.0
4 6 12.0
Group 1= Diabetic HD patients
Group 2= Nondiabetic HD patients
all the vessels except on the carotid sites. They concluded that 
the process of advance atherosclerosis might be started with the 
beginning of kidney failure. They suggested that hemodialysis 
treatment may not a potential factor to accelerate arthrosclerosis. 
They concluded that the progression of atherosclerosis might be 
related to atherogenic factors operative before regular dialysis 
(11). Savage et al. in an investigation on 24 dialysis patients 
detected, the more prevalence of plaque in carotid and femoral 
artery. Also this study showed, the association between femoral 
artery plaque and age (4). Mallion et al. (14) found that the 
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prevalence of arterial changes is more evident in subjects with 
left ventricular hypertrophy. They believed that when there is 
left ventricular hypertrophy, this arterial changes is similar in 
severity to the left ventricular hypertrophy and in particular 
concentric. 
Conclusion
Our results provide the evidence of the association of 
carotid-femoral plaques with left ventricular hypertrophy 
and especially inverse correlation of plaque score with left 
ventricular ejection fraction, means that arterial plaques 
and cardiovascular involvement especially left ventricular 
hypertrophy in hemodialysis patients could have an 
atherosclerotic base although other factors are involved in this 
process. The association of carotid-femoral arterial plaques to 
left ventricular hypertrophy may confirm the arterial-cardiac 
interaction and further highlights the importance of structural 
changes in large arteries of the pathogenesis of left ventricular 
hypertrophy in hemodialysis patients. However, the question is 
whether carotid ultrasonography added applicable information 
to echocardiography measured left ventricular hypertrophy 
in hemodialysis patients. Therefore in the meantime further 
clinical study into this important aspect of hemodialysis 
patients is needed.
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